Crazy Biotech Bubble we are in. What happened to the days when an early stage development company was priced accordingly? Now it's a case of price in best case scenario [or better] and roll the dice. Amazing to see a poster here try to justify an insane valuation based on ZERO clincial trial results. How times have changed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.